Pfizer (PFE) reports positive Phase 2 results for its 25-valent pediatric pneumococcal vaccine candidate, showing robust immunogenicity, broader protection across 25 serotypes and enhanced serotype 3 responses versus PREVNAR 20

Newsquawk StaffPublished On the live feed at 6 more headlines followed before this page went public
Newsquawk headlinesUTC

Iran-Pakistan cooperation had declined/stopped over the past two weeks, Al Arabiya and Al Hadath reports citing a senior diplomatic source 

Russian Government aide Ushakov says there is no discussion at this point about a separate Russian-US summit, IFX reports; leaders could meet at the November APEC summit in China

Pfizer (PFE) reports positive Phase 2 results for its 25-valent pediatric pneumococcal vaccine candidate, showing robust immunogenicity, broader protection across 25 serotypes and enhanced serotype 3 responses versus PREVNAR 20

[MARKET ANALYSIS] Fixed benchmarks find some reprieve as energy prices pull back, Gilts outperform post-CPI

Pakistan's Interior Minister Naqvi is on route to Tehran, according to Journalist Mallick

Open the platform and use it. The whole workspace is free to try, with no signup and no card. When you want the headlines arriving live instead of on a delay, Newsquawk Pro is £24.99 for 7 days.

Free. No signup, no card.
  • The candidate was well tolerated with no safety concerns. Pfizer has initiated its Phase 3 pediatric programme and advanced its adult programme to a 35-valent candidate.

Related headlines

The whole workspace, free to try.

Try it free